We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HXL icon
851
Hexcel
HXL
$7.97B
$641K ﹤0.01%
10,375
+587
+6% +$36.9K
HLN icon
852
Haleon
HLN
$45.3B
$640K ﹤0.01%
60,448
-265
-0.4% -$2.56K
AROC icon
853
Archrock
AROC
$6.16B
$637K ﹤0.01%
31,485
+838
+3% +$17K
PWB icon
854
Invesco Large Cap Growth ETF
PWB
$2.17B
$636K ﹤0.01%
6,442
CCC
855
CCC Intelligent Solutions
CCC
$3.55B
$631K ﹤0.01%
57,073
+10,334
+22% +$112K
SCI icon
856
Service Corp International
SCI
$11.8B
$630K ﹤0.01%
7,985
-9,059
-53% -$689K
AIN icon
857
Albany International
AIN
$2.09B
$628K ﹤0.01%
7,065
-458
-6% -$40.3K
IBP icon
858
Installed Building Products
IBP
$6.21B
$627K ﹤0.01%
+2,546
New +$576K
XHB icon
859
State Street SPDR S&P Homebuilders ETF
XHB
$1.61B
$627K ﹤0.01%
5,033
SU icon
860
Suncor Energy
SU
$77.7B
$627K ﹤0.01%
16,979
+2,211
+15% +$85.4K
HOLX
861
DELISTED
Hologic
HOLX
$626K ﹤0.01%
7,686
+68
+0.9% +$5.44K
HBAN icon
862
Huntington Bancshares
HBAN
$34B
$623K ﹤0.01%
42,377
-119,692
-74% -$1.7M
CPRT icon
863
Copart
CPRT
$28.5B
$622K ﹤0.01%
11,877
-4,918
-29% -$255K
MOG.A icon
864
Moog Inc Class A
MOG.A
$12.4B
$620K ﹤0.01%
3,068
-189
-6% -$35.6K
WDFC icon
865
WD-40
WDFC
$2.98B
$619K ﹤0.01%
2,399
-267
-10% -$67K
FTAI icon
866
FTAI Aviation
FTAI
$20.2B
$618K ﹤0.01%
4,653
-4,776
-51% -$541K
DAL icon
867
Delta Air Lines
DAL
$56.7B
$617K ﹤0.01%
12,149
-278
-2% -$12.1K
URTH icon
868
iShares MSCI World ETF
URTH
$7.83B
$616K ﹤0.01%
3,927
AAXJ icon
869
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.51B
$614K ﹤0.01%
7,821
COO icon
870
Cooper Companies
COO
$14.2B
$610K ﹤0.01%
5,530
-4
-0.1% -$389
ARCB icon
871
ArcBest
ARCB
$3.15B
$609K ﹤0.01%
5,611
+1,144
+26% +$126K
BLKB icon
872
Blackbaud
BLKB
$1.94B
$607K ﹤0.01%
7,169
+846
+13% +$67.4K
PRFZ icon
873
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.74B
$607K ﹤0.01%
14,602
WERN icon
874
Werner Enterprises
WERN
$2.2B
$600K ﹤0.01%
15,543
+8,188
+111% +$303K
GTLB icon
875
GitLab
GTLB
$5.75B
$596K ﹤0.01%
11,564
+334
+3% +$16.7K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.